Intellia Therapeutics
NTLA
NTLA
288 hedge funds and large institutions have $2.02B invested in Intellia Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 113 increasing their positions, 88 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $2.51B → $2.02B (-$497M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
32% less call options, than puts
Call options by funds: $18.7M | Put options by funds: $27.6M
Holders
288
Holding in Top 10
4
Calls
$18.7M
Puts
$27.6M
Top Buyers
| 1 | +$13.6M | |
| 2 | +$13.2M | |
| 3 | +$12.6M | |
| 4 |
BlackRock
New York
|
+$10.9M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$10.8M |
Top Sellers
| 1 | -$75.7M | |
| 2 | -$9.23M | |
| 3 | -$8.51M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$8.36M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$7.68M |